- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Mar 31, 2026 | 61.66M sh |
| Shares Outstanding | Q1 2026 · Dec 31, 2025 | 58.21M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $1.93M |
| Capex | Q1 2026 · Mar 31, 2025 | $7.62M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$46.69M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$51.52M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $143.86M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $167.2M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $312.42M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2024 | $561.57M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $443.15M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $508.59M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $647.43M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $716.06M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $79.6M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $95.97M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $589.92M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $611.11M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $409.96M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $471.84M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.03B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.12B |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.39 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$1.68 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $37.83M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $39.72M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $49.92M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $70.92M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$82.59M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$90.96M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$71.37M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$80.97M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $3.1M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $4.09M |
| Revenue | Q1 2026 · Mar 31, 2026 | $19.47M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $38.23M |